Methotrexate-associated Classical Hodgkin Lymphoma Shows Distinct Clinicopathological Features but Comparable Clinical Outcomes With Sporadic Cases
Conclusion: The present study revealed differences in clinicopathological features but similarities in clinical outcomes of MTX-CHL and sporadic CHL.
Source: In Vivo - Category: Research Authors: YOSHIFUJI, K., UMEZAWA, Y., ICHIKAWA, A., WATANABE, K., MIURA, O., YAMAMOTO, M. Tags: Clinical Studies Source Type: research
More News: Chemotherapy | Hodgkin's Disease | Lymphoma | Methotrexate | Rare Diseases | Research | Study